Bioteque Corporation (4107.TWO)
TWD 110.5
(-2.21%)
TWD 110.5
(-2.21%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 894.74 Million TWD | 2.54% |
| 2022 | 872.6 Million TWD | 84.16% |
| 2021 | 473.82 Million TWD | 19.88% |
| 2020 | 395.24 Million TWD | 490.58% |
| 2019 | 66.92 Million TWD | -38.54% |
| 2018 | 108.88 Million TWD | -46.91% |
| 2017 | 205.09 Million TWD | 21.49% |
| 2016 | 168.81 Million TWD | -45.56% |
| 2015 | 310.11 Million TWD | 39.36% |
| 2014 | 222.52 Million TWD | 26.88% |
| 2013 | 175.38 Million TWD | 6.58% |
| 2012 | 164.55 Million TWD | -26.82% |
| 2011 | 224.85 Million TWD | -11.0% |
| 2010 | 252.64 Million TWD | -3.53% |
| 2009 | 261.9 Million TWD | 40.36% |
| 2008 | 186.59 Million TWD | -18.93% |
| 2007 | 230.16 Million TWD | -47.66% |
| 2006 | 439.72 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 831.05 Million TWD | -5.61% |
| 2024 Q1 | 880.49 Million TWD | -1.59% |
| 2023 FY | 894.74 Million TWD | 2.54% |
| 2023 Q3 | 909.84 Million TWD | 3.48% |
| 2023 Q1 | 859.15 Million TWD | -1.54% |
| 2023 Q2 | 879.26 Million TWD | 2.34% |
| 2023 Q4 | 894.74 Million TWD | -1.66% |
| 2022 Q2 | 451.46 Million TWD | 0.51% |
| 2022 Q1 | 449.15 Million TWD | -5.21% |
| 2022 FY | 872.6 Million TWD | 84.16% |
| 2022 Q3 | 742.13 Million TWD | 64.39% |
| 2022 Q4 | 872.6 Million TWD | 17.58% |
| 2021 Q1 | 429.27 Million TWD | 8.61% |
| 2021 Q3 | 483.42 Million TWD | 13.16% |
| 2021 Q4 | 473.82 Million TWD | -1.99% |
| 2021 FY | 473.82 Million TWD | 19.88% |
| 2021 Q2 | 427.21 Million TWD | -0.48% |
| 2020 Q3 | 460.26 Million TWD | 207.5% |
| 2020 Q1 | 58.05 Million TWD | -13.26% |
| 2020 FY | 395.24 Million TWD | 490.58% |
| 2020 Q2 | 149.68 Million TWD | 157.84% |
| 2020 Q4 | 395.24 Million TWD | -14.13% |
| 2019 Q3 | 135.4 Million TWD | -8.56% |
| 2019 Q4 | 66.92 Million TWD | -50.57% |
| 2019 FY | 66.92 Million TWD | -38.54% |
| 2019 Q2 | 148.08 Million TWD | 61.43% |
| 2019 Q1 | 91.73 Million TWD | -15.76% |
| 2018 FY | 108.88 Million TWD | -46.91% |
| 2018 Q4 | 108.88 Million TWD | -38.94% |
| 2018 Q1 | 195.14 Million TWD | -4.85% |
| 2018 Q2 | 194.31 Million TWD | -0.42% |
| 2018 Q3 | 178.31 Million TWD | -8.23% |
| 2017 Q4 | 205.09 Million TWD | -10.19% |
| 2017 Q2 | 207.17 Million TWD | 26.76% |
| 2017 Q1 | 163.43 Million TWD | -3.19% |
| 2017 FY | 205.09 Million TWD | 21.49% |
| 2017 Q3 | 228.36 Million TWD | 10.23% |
| 2016 FY | 168.81 Million TWD | -45.56% |
| 2016 Q1 | 247.54 Million TWD | -20.18% |
| 2016 Q2 | 223.93 Million TWD | -9.54% |
| 2016 Q3 | 218.83 Million TWD | -2.28% |
| 2016 Q4 | 168.81 Million TWD | -22.86% |
| 2015 FY | 310.11 Million TWD | 39.36% |
| 2015 Q4 | 310.11 Million TWD | 50.36% |
| 2015 Q3 | 206.24 Million TWD | 1.93% |
| 2015 Q2 | 202.32 Million TWD | -17.9% |
| 2015 Q1 | 246.43 Million TWD | 10.74% |
| 2014 Q1 | 175.36 Million TWD | -0.01% |
| 2014 FY | 222.52 Million TWD | 26.88% |
| 2014 Q3 | 207.92 Million TWD | 13.53% |
| 2014 Q2 | 183.14 Million TWD | 4.44% |
| 2014 Q4 | 222.52 Million TWD | 7.02% |
| 2013 Q2 | 156.84 Million TWD | -3.11% |
| 2013 Q3 | 304.92 Million TWD | 94.4% |
| 2013 Q4 | 175.38 Million TWD | -42.48% |
| 2013 FY | 175.38 Million TWD | 6.58% |
| 2013 Q1 | 161.89 Million TWD | -1.62% |
| 2012 Q1 | 210.55 Million TWD | -6.36% |
| 2012 Q2 | 179.7 Million TWD | -14.65% |
| 2012 Q3 | 171.11 Million TWD | -4.78% |
| 2012 Q4 | 164.55 Million TWD | -3.83% |
| 2012 FY | 164.55 Million TWD | -26.82% |
| 2011 Q2 | 231.37 Million TWD | -1.15% |
| 2011 Q3 | 231.55 Million TWD | 0.08% |
| 2011 Q4 | 224.85 Million TWD | -2.89% |
| 2011 FY | 224.85 Million TWD | -11.0% |
| 2011 Q1 | 234.06 Million TWD | -7.36% |
| 2010 Q4 | 252.64 Million TWD | 0.0% |
| 2010 FY | 252.64 Million TWD | -3.53% |
| 2009 FY | 261.9 Million TWD | 40.36% |
| 2008 FY | 186.59 Million TWD | -18.93% |
| 2007 FY | 230.16 Million TWD | -47.66% |
| 2006 FY | 439.72 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 662.27 Million TWD | -35.101% |
| Chi Sheng Pharma & Biotech Co., Ltd | 120 Million TWD | -645.618% |
| Sunder Biomedical Tech. Co., Ltd. | 491.28 Million TWD | -82.122% |
| BenQ Medical Technology Corporation | 1.23 Billion TWD | 27.623% |
| Pacific Hospital Supply Co., Ltd | 437.43 Million TWD | -104.543% |
| Unicon Optical Co., Ltd. | 281.6 Million TWD | -217.727% |
| Formosa Optical Technology Co.,Ltd. | 2.91 Billion TWD | 69.342% |
| Medeon Biodesign, Inc. | 47.14 Million TWD | -1797.849% |
| Concord Medical Co., Ltd. | 216.04 Million TWD | -314.153% |
| Crystalvue Medical Corporation | 25.03 Million TWD | -3474.674% |
| Perfect Medical Industry Co., Ltd. | 211.96 Million TWD | -322.127% |
| ICARES Medicus, Inc. | 121.63 Million TWD | -635.589% |
| Lagis Enterprise Co., Ltd. | 177.66 Million TWD | -403.625% |
| Amed Co., Ltd. | 257.39 Million TWD | -247.619% |